SBIR/STTR Research Award

Pulsed Imaging Through Biological Tissue by Nonlinear Optics

Award identifier 0b538cd4d30ae42d22a7c249ea5b3e7104e9d8132be9cd39df5df1643f13f18dAwarding agency Department of Defense · Defense Advanced Research Projects Agency

Award amount

$99,952

Program and phase

SBIR · Phase I

Award year

1994

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Advanced Research Projects Agency
Recipient company
Science Research Laboratory, Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
MKKPT9RCLJQ1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Nolinear optical imaging is proposed for in-vivo detection and imaging through biological tissue. A major application is clinical optical mammographic screening for breast cancer. Unlike conventional x-ray mammography, the proposed optical imaging technique utilizes visible radiation. Since this non-ionizing radiation poses no risk of radiation-induced carcinoma, nolinear optical breast-cancer screening examinations can be repeated periodically with no risk to the patient-a revolutionary development. This advance would be valuable to both civilian and military hospitals. The technology is alos applicable to underwater imaging, which is of interest to the Navy. Nonlinear optical imaging utilizes a single low-peak-power repetitively pulsed light source. The presence of lesions, whose absorption and/or scattering properties differ from those of the sorrounding tissue, can be determined from observation of the light transmitted through the tissue. The technique relies on nonlinear optics in specific media that function under extremely low light-power conditions and can operate in a relatively compact geometry. These nonlinear optical media provide high spatial resolution by temporally gating and amplifying light that has undergone minimum scattering, thereby discriminating against highly scattered light. The goal is an optical scan of duration 1 sec to detect submillimeter-size lesions in a 40 mm thic breast. Phase I is a theoretical effort to assess the feasibility of the technique and design a Phase II proof-of-principle laboratory demonstration. Anticipated Benefits: The major application of a nonlinear-optics imaging system is rapid, safe optical mammography suitable for clinical screening for breast cancer. Unlike a conventional x-ray mammogram, a nonlinear optical scan poses no risk of radiation-induced cancer. With an estimated US market of tens of millions of examinations per year, its widespread commercial application is assured. The technology that will be developed also has other applications, including underwater imaging.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

228 SBIR/STTR records share this UEI (1984–2020). Reported award amounts total $66,288,679. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Energy, National Science Foundation, Department of Health and Human Services, National Aeronautics and Space Administration, Department of Transportation

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.